Biofrontera Inc.BFRIEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Biofrontera Inc. is a specialty biopharmaceutical enterprise focused on developing and commercializing prescription dermatological products. Its core product line targets skin conditions including actinic keratosis and other dermatological disorders, with primary operating markets in the United States and European Union, serving patients and dermatology care providers.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Laurence W. Lytton | 9.99% | 554.9K | flat | 2024-11-14 |
| S.S. OR | 9.90% | 504.2K | — | 2024-05-07 |
| s. AIGH Capital Management, LLC | 9.90% | 501.4K | — | 2024-03-20 |
| NOS. OF ABOVE PERSONS | 6.90% | 426.0K | ▼ -2.00pp | 2024-11-06 |
| Armistice Capital, LLC | 4.99% | 291.1K | ▼ -5.00pp | 2024-11-14 |
| Nabil | 0.00% | 9.1K | ▼ -6.09pp | 2024-11-13 |
| Bigger Capital Fund, LP | — | 10.0K | — | 2024-11-01 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-05 | Leffler Eugene Frederick | Chief Financial Officer | Option exercise | 87.5K | — | — |
| 2026-03-05 | Hermann Luebbert | CEO & Chairman | Option exercise | 137.5K | — | — |
1–2 of 2